ABSTRACT
Many clinical experts in different inflammatory diseases believe that combination treatment is safer, more efficacious and will prevail in the future than single-agent therapy. Several immunosuppressive drugs developed during the past few years have shown remarkable potency. The concept of combination therapy has been demonstrated very fruitfully in oncology and in infectious diseases. It has been also demonstrated to be strongly efficacious in transplantation and in rheumatoid arthritis.
